Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies
Open Access
- 1 November 2022
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (2) , 688-693
Abstract
Purpose: To compare two strategies: Prostate-specific antigen density (PSAd) and lesion volume measurement in ruling out significant prostate cancer (sPCa) in men with equivocal Prostate Imaging Reporting and Data System (PI-RADS) category 3 index lesions on biparametric magnetic resonance imaging. Methods: In total, 130 men from our database had index lesions with PI-RADS scores of 3. Prostate volume was measured using the ellipsoid method, in accordance with PI-RADS version 2.1 criteria. Index lesion volumes were also measured using the ellipsoidal formula on the diffusion-weighted imaging sequence with the highest b-value and sagittal T2 sequences. Results: Among 130 men with PI-RADS category 3 index lesions, 23 (18%) had sPCa. In total, 6 of the 89 men with PSAd < 0.15 ng/mL2 (7%) had sPCa, whereas 8 of the 49 men with index lesion volumes < 0.5 mL (16%) had sPCa. The difference was statistically significant (McNemar, p < 0.0001). Conclusion: The PSAd strategy performed better than the lesion volume strategy in ruling out sPCa in men with equivocal PI-RADS category 3 index lesions.Keywords
Funding Information
- Inge og Jørgen Larsens Mindelegat (20009)
This publication has 20 references indexed in Scilit:
- Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?World Journal of Urology, 2017
- Biparametric versus multiparametric MRI in the diagnosis of prostate cancerActa Radiologica Open, 2016
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2016
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2016
- The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2005
- NONPALPABLE STAGE T1C PROSTATE CANCER: PREDICTION OF INSIGNIFICANT DISEASE USING FREE/TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS AND NEEDLE BIOPSY FINDINGSJournal of Urology, 1998
- Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen LevelsJournal of Urology, 1995
- Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen LevelsJournal of Urology, 1995
- The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic TestsJournal of Urology, 1994
- Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer.1994